With Transcatheter Cardiovascular Therapeutics (TCT) meeting quickly approaching next week, one device industry experts have on the radar is the Absorb drug eluting bioresorbable vascular scaffold (BVS) from Abbott (Abbott Park, Illinois). The device, which is for the treatment of coronary artery disease and has been a decade in the making, recently became available across Europe and parts of Asia Pacific and Latin America (Medical Device Daily, Sept. 26, 2012). Read More
